Carphenazine in the treatment of schizophrenic psychoses. Controlled clinical trial.

Article Details

Citation

Copy to clipboard

Vinar O, Formankova M, Taussigova D, Ruzicka S

Carphenazine in the treatment of schizophrenic psychoses. Controlled clinical trial.

Act Nerv Super (Praha). 1967 Nov;9(4):353-5.

PubMed ID

4889058 [ View in PubMed

]

Abstract

Not Available

DrugBank Data that Cites this Article

Drug Targets

Drug	Target	Kind	Organism	Pharmacological Action	Actions
Carphenazine	Dopamine D1 receptor	Protein	Humans	Yes	Antagonist	Details
Carphenazine	Dopamine D2 receptor	Protein	Humans	Yes	Antagonist	Details
Carphenazine	Dopamine D5 receptor	Protein	Humans	Yes	Antagonist	Details